Lipocine Inc. (LPCN) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 7 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for LPCN is $15.00, representing a +485.9% upside from the current price of $2.56. Price targets range from a low of $15.00 to a high of $15.00.
